Request Legal Help Now - Free

< Back to Press Releases

Many people who sought legal help from now participate in $700 million dollar Zyprexa settlement

Multi-million dollar legal settlement from pharmaceutical giant, Eli Lilly, for those U.S. patients adversely affected by Zyprexa - antipsychotic pharmaceutical drug.

Seattle, Washington - Zyprexa-related complaints continue to come in through while Eli Lilly & Co settle with $700 million dollar in damages, hoping it will fulfill the majority of nationwide patient grievances.

In recent nationwide news and lawsuits, Eli Lilly & Co. has received attention from the FDA, doctors, patients, and their lawyers for complaints of hyperglycemia and diabetes from unrevealed Zyprexa side effects. Zyprexa (Olanzapine) is typically prescribed to those with symptoms of schizophrenia, dementia, bipolar mania disorder, or other similar mental illnesses. This widely prescribed drug now claims several adverse side effects including risk of hyperglycemia, diabetes, strokes, tardive dyskinesia (TD), and neuroleptic malignant syndrome (NMS), a life-threatening problem affecting kidneys and nervous system. To date, there have been 288 reported diabetes cases and 23 alleged fatalities from Zyprexa.

Eli Lilly & Co. is accused of heavily promoting Zyprexa as a safe and effective drug for psychotic disorders, while virtually concealing the risks of side effects from doctors and patients. This current settlement only covers the cases of diabetes-related conditions from using Zyprexa prior to the warning label changes in 2003.

While the health and drug control agencies of Japan and Great Britain issued Zyprexa warnings in 2002, the U.S. Food and Drug Administration approved the drug's continued distribution. Then in September 2003, the FDA required label warning changes for Zyprexa and all atypical anti-psychotic drugs. In a recent analysis, the FDA noted that older patients using Zyprexa, an atypical antipsychotic, had "a higher chance for death than patients who did not take the medicine".

Zyprexa has been the blockbuster drug for Eli Lilly, bringing in over $4 billion of its $13 billion net sales in 2004. The global pharmaceutical giant produces other drugs for psychotic disorders such as Prozac, Strattera, and Symbyax.

For more information visit,

About Online Legal Services Ltd (OLS) and offers a comprehensive website with up-to-date legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can receive free case evaluations. Justice for Everyone.
Contact us at:

Request Legal Help Now! - Free